Market Forecasts and Industry Analysis Peptide Therapeutics Market By Application (Cancer

Request a Sample Copy of This Report @ https://www.radiantinsights.com/research/peptide-therapeutics- market/request-sample Further Key Findings From the Study Suggest: • Cancer held the largest market share in 2016 owing to increasing demand for alternative therapeutics over conventional treatment options. Peptides are being used as potential therapeutic agents in cancer treatment. • The generic drug segment is expected to showcase upward shift due to patent expiration of blockbuster peptides and supportive government initiatives pertaining to the introduction of generic class • Outsourced manufacturing is expected to grow at CAGR of 6.7% owing to requirements of complex procedures and shift in preference toward outsourcing, which helps in eliminating cost of production. • Route of administration including nasal and intradermal routes is expected to grow at a rapid pace owing to ease of usage and advantages over other routes of administration such as oral. • Hybrid technology is expected to spearhead the growth of this market. Benefits associated with this technology such as time conservation and ease of usage for both solid- and liquid-phase peptide synthesis are the key factors affirming growth. • North America held the largest share in terms of revenue in 2016 owing to higher level of awareness pertaining to genomics & proteomics products, well-established R&D infrastructure, and rising funding initiatives • Asia Pacific industry is expected to showcase lucrative growth over the forecast period with CAGR of 11.0%. Presence of established generic industry and API providers in this region coupled with growing economic stability in some of the countries is expected to propel market growth. See More Reports of This Category by Radiant Insights @ https://www.radiantinsights.com/catalog/pharmaceutical Follow Us:

Market Forecasts and Industry Analysis Peptide Therapeutics Market By Application (Cancer | Page 2